Graphene Ventures
VC Fund
Palo Alto, United States
Graphene Ventures is a venture capital firm that focuses on early and growth stage tech companies in enterprise software,consumer technology, health tech, fintech and blockchain technologies
- Total investments:
- 59
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Graphene Ventures invests in
Stages Graphene Ventures invests in
Countries Graphene Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.4M–$7M
- Series A
- $5.1M–$27M
- Venture - Series Unknown
- $5.2M–$170M
Investment Focus
Industry
- Software 13 (22%)
- Health Care 5 (8%)
- Information Technology 5 (8%)
- FinTech 4 (7%)
- E-Commerce 4 (7%)
Stage
- Series A 20 (34%)
- Seed 16 (27%)
- Venture - Series Unknown 4 (7%)
- Series F 3 (5%)
- Series B 2 (3%)
Country
- United States 19 (32%)
- Brazil 7 (12%)
- Saudi Arabia 3 (5%)
- United Kingdom 3 (5%)
- Egypt 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Nabil Alnoor Borhanu
Founding General Partner
|
Founding General Partner | Total investments: 14 | Find email | |
Alex Giannikoulis
Founder & General Partner
|
Founder & General Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Decoda Health develops an autonomous medical coding and billing solution. | $4M / Seed / Nov 11, 2025 | ||
| Smartlens is a clinical-stage Med Tech company with a portfolio of technologies to treat and diagnose Glaucoma - a chronic eye disease and the leading cause of irreversible blindness. The Company is running clinical trials with its novel eye pressure (IOP) monitoring contact lens (miLens) that will help improve clinical outcomes in Glaucoma. Thedisease affects hundreds of millions around the globe; even in developed countries more than 50% of the patients are currently undiagnosed, and more than 38% are going blind despite being treated. The need for monitoring eye pressure outside the clinic has been defined as an urgent need by scientific, medical, and industry leaders in ophthalmology that will help improve clinical outcomes. Smartlens’ flagship product miLens is a non-invasive and convenient way of monitoring eye pressure for anyone anywhere at any time. It will help improve early diagnosis, enable personalized treatments, and disease monitoring thus reducing the prevalence of blindness, treatment costs, and its huge burden on lives and economies. miLens is utilizing a novel, electronics-free sensor technology that is fully owned by Smartlens, Inc. and protected by its portfolio of issued and pending patents covering more than 40 countries. The Company's novel technology is also being studied at Stanford University Labs for monitoring (ICP) which is associated with certain neurological disorders, and cancers. Smartlens also owns a non-invasive drug delivery technology that monitors the IOP and releases the right medication at the right time which will help improve efficacy, patient compliance and reduce the side effects. Smartlens is the Winner of the 2021 "Outstanding Innovation in Medical Technology and Life Sciences" of High-Tech Awards by Octane. The Company has been invited to various national and international conferences, published its studies, listed among the Top 10 MedTech Startups, and featured in ABC7, Fortune, BBC, and Nature Medicine. | $5.2M / Venture - Series Unknown / Oct 14, 2025 | ||
| CUB develops a platform that automates the management of receivables and after-sales for subdivisions. It replaces manual routines to save time, and resources, and reduce bad debt. | $5.6M / Series A / Sep 17, 2025 | ||
| WakeCap is an IoT-based enterprise solution to improve safety & productivity in the construction site. We enable construction companies to have real-time field reporting by connecting & tracking materials, equipments, and most importantly workers at the construction site. | $28M / Series A / May 13, 2025 | ||
| Start Careers offers Publicize the vacancies in a practical way to the best universities in the country. | $2.2M / Seed / Apr 14, 2025 | ||
| AeroVect develops autonomous driving platforms for GSE, enabling efficient, safe, and reliable airside operations at some of the largest passenger and cargo hubs in the world. | $18M / Series A / Sep 19, 2024 | ||
| Datalogz is a BI Ops platform that provides visibility into business intelligence environments. The company was founded in 2020 and is headquartered in Queens, New York, United States. | $5M / Series A / Dec 14, 2023 | ||
| Start Careers offers Publicize the vacancies in a practical way to the best universities in the country. | $1.4M / Seed / Dec 11, 2023 | ||
| Retailo is the fastest growing B2B startup in MENAP and has digitized retail supply chains in the region. Founded in July 2020 by former Careem executives Talha Ansari, Wahaj Ahmed and Mohammad Nowkhaiz, Retailo has raised $9 million in just 9 months thanks to a diverse group of international investors that include institutions from Silicon Valley,UK, and GCC and also high net worth individuals (HNWs).Headquartered in Riyadh and operational in multiple markets in MENAP, Retailo currently provides services to over 35,000 active retailers that can access more than 2,000 SKUs from the Retailo app which are delivered to them within 24-hours of order placement. Retailo’s 500+ colleagues are spread across multiple cities in MENAP and fulfil tens of thousands of retailers’ orders every month. This vast operation is managed through multiple warehouses that store inventory from hundreds of brands, many of which are direct Retailo partners.Retailo’s mission is to simplify the retail business and make supply chains easily accessible and beautifully uncomplicated. Through its high-powered app, driven teams and smart operations, Retailo will unlock the earning potential of 10 million SME retailers in MENAP and lift the economy of the entire region. | $15M / Venture - Series Unknown / Nov 27, 2023 | ||
| FluidAI Medical is a medical platform company at the forefront of revolutionizing global patient care, leveraging the transformative power of artificial intelligence in post-operative recovery. | $14.6M / Series A / Oct 10, 2023 | ||
| See all 59 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Graphene Ventures invest in?
Graphene Ventures invests primarily in Software, Health Care and Information Technology startups, most often at Series A and Seed stage. Most of the 59 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Graphene Ventures's check size?
Graphene Ventures typically joins rounds of $1.4M–$7M at Seed, $5.1M–$27M at Series A and $5.2M–$170M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Graphene Ventures participates in.
How do I contact Graphene Ventures?
Public channels for Graphene Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Graphene Ventures?
The team at Graphene Ventures includes Nabil Alnoor Borhanu (Founding General Partner) and Alex Giannikoulis (Founder & General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
